1. All Products
  2. BECLOMETASONE dipropionate, 50mcg/puff, 200 puffs, aerosol
Public Pricelist

BECLOMETASONE dipropionate, 50mcg/puff, 200 puffs, aerosol

https://medicalguidelines.msf.org/en/node/363
https://unicat.msf.org/cat/product/11911
STD DORABECL5SF

Valid Article

Former Code(s): -X DORABECL5S-
Article is intended to be used with children (<12 years) ONLY.
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03BA01
Anatomical Therapeutic Chemical Classification according to WHOCC
UN1950
Hazardous materials and products (identified by their 4-digit transport UN-number) must be transported under certain conditions as specified in the MSDS sheet (Material Safety Data Sheet).
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/569037/image_1920?unique=7412bfb

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

BECLOMETASONE dipropionate, aerosol

Therapeutic Action

Inhaled CorticoSteroid (ICS)

Glucocorticoid with anti-inflammatory effects in the lungs, resulting in reduced asthma symptoms and exacerbations, with less adverse effects compared to systemic corticosteroids.

Indications

Maintenance treatment of chronic asthma after initial treatment with inhaled short-acting beta2 agonist (SABA) like salbutamol.

Chronic Obstructive Pulmonary Disease (COPD) following treatment with inhaled salbutamol and salmeterol.

Instructions for use

Suspension or solution in a Pressurised Metered-Dose Inhaler (MDI): a small canister containing a mixture of medicine and pressurised propellant. The pressure from the propellant delivers the medication from the canister when the canister is pushed down into the boot/actuator.

Method of administration

  • Shake the inhaler and ensure that liquid can be heard. Remove the mouthpiece cover.
  • Inhale fully, then exhale as completely as possible.
  • Place the lips firmly around the mouthpiece..
  • Start to inhale with a long, slow breath and continue breathing deeply while activating the inhaler (puff).
  • Remove the inhaler, close the lips, and hold the breath for 10 seconds or as long as comfortable.
  • Exhale, wait a few seconds, shake the inhaler again, and repeat for the next puff, if needed.
  • Replace the mouthpiece cover after use.

Manufacturers may express the content per puff as a "metered dose" (the quantity of the drug in the device metering chamber, excluding the valve) or as a "delivered dose" (the quantity of drug delivered to the user, excluding the mouthpiece). Always refer to the product leaflet.

The inhalers generally supplied by MSF are pressurised metered-dose inhalers (MDI). Refer to the information leaflet for appropriate instructions for use according to the inhaler model.

The pressurised metered-dose inhalers are CFC free. Chlorofluorocarbons (CFCs) are harmful to the ozone layer, and HFA (hydrofluoroalkane) propellants are a more effective, environmentally friendly alternative.

In adults and adolescents, when beclametasone is used in combination with a long-acting beta2 agonist (LABA), a combination inhaler is available: BECLOMETASONE dipr.100mcg/ FORMOTEROL fum. 6mcg/puff 120p, aer.

Image

Precautions for Use

Beclometasone is not a bronchodilator. For asthma attacks, use inhaled salbutamol.

In children, use an inhalation chamber/spacer with or without a mask (depending on the child's age) for each administration of a pressurised metered- dose inhaler.

In patients who have difficulty coordinating the actuation of the metered-dose inhaler and inhalation (e.g., elderly patients), use an inhalation chamber/spacer to facilitate administration and improve the effectiveness of the product.

Do not use any mouthpiece other than the one provided with the inhaler.

Transport Dangerous Goods

UN transport code:

  • UN 1950 - Aerosols, non-flammable (each not exceeding 1 L capacity)
  • Transport Class 2.2 - Non-flammable, non-toxic gases

Transport is only regulated for large quantities of aerosols.

Storage

  • Below 25ºC - Protect from sunlight
  • Used aerosols: do not pierce or incinerate. Empty any residual gas, then dispose of by burying.
Image